# TOFACITINIB

NDC: 59651-459
Generic name: TOFACITINIB
Labeler / Manufacturer: Aurobindo Pharma Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20260603

FDA application: ANDA215356

## Active ingredients

- TOFACITINIB CITRATE: 5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"59651-459"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=59651-459
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=50962b08-99dd-ae73-e063-6394a90ad1eb